CervoMed to Participate in the Canaccord Genuity 45th Annual Growth Conference
CervoMed to Participate in the Canaccord Genuity 45th Annual Growth Conference GlobeNewswire August 05, 2025 BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that Company management will participate in a fireside chat and one-on-one investor meetings at the […]